Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial-Reference-Cited by-同舟云学术

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Published:2014-11 Issue:5 Volume:168 Page:682-689.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Schwartz Gregory G.,Bessac Laurence,Berdan Lisa G.,Bhatt Deepak L.,Bittner Vera,Diaz Rafael,Goodman Shaun G.,Hanotin Corinne,Harrington Robert A.,Jukema J. Wouter,Mahaffey Kenneth W.,Moryusef Angèle,Pordy Robert,Roe Matthew T.,Rorick Tyrus,Sasiela William J.,Shirodaria Cheerag,Szarek Michael,Tamby Jean-François,Tricoci Pierluigi,White Harvey,Zeiher Andreas,Steg Philippe Gabriel

Funder

Sanofi-Aventis SA

Regeneron Pharmaceuticals

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Effects of dalcetrapib in patients with a recent acute coronary syndrome;Schwartz;N Engl J Med,2012

2. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

3. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial;Schwartz;JAMA,2001

4. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

5. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study);Fox;Eur Heart J,2010

Cited by 369 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From genetic associations to genes: methods, applications, and challenges;Trends in Genetics;2024-08

2. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

3. Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions;Biomedicines;2024-07-26

4. Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study;Journal of Clinical Lipidology;2024-07

5. The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy;Biomedicines;2024-04-26